General - Press Releases

Date	Title	Company
10-Nov-2022	Bicycle Therapeutics to Present Five Posters Highlighting Preclinical Data from its Bicycle Tumor-Targeted Immune Cell Agonist® (Bicycle TICA®) Programs at the SITC 37th Annual Meeting	Businesswire
10-Nov-2022	Wolters Kluwer CT Corporation Podcast Examines New Compliance Obligations Under the Corporate Transparency Act	Businesswire
10-Nov-2022	Klick Health Builds Out Global Leadership Team and Offices	Businesswire
10-Nov-2022	IconOVir Announces New Preclinical Data Showcasing Best-in-Class Potential of ICVB-1042, its Lead Oncolytic Virus, at SITC 2022	Businesswire
10-Nov-2022	Imvax Presents Preclinical Data at SITC 2022 Supporting Mechanism of Action and Anti-tumor Activity of its Immunotherapy Platform Across Multiple Tumor Types	Businesswire
10-Nov-2022	Transaction Data Systems Adds Cardinal Health’s Outcomes Platform to Enable Greater Clinical Services	Businesswire
10-Nov-2022	Catamaran Bio Presents Preclinical Efficacy Data for Two Allogeneic CAR-NK Cell Therapies for Solid Tumors at SITC 2022 Annual Meeting	Businesswire
10-Nov-2022	Asher Bio Presents New Preclinical Data at SITC 2022 Further Supporting Advancement of AB248 and AB821 as Highly Differentiated Cis-targeted Cancer Immunotherapies	Businesswire
10-Nov-2022	Seagen to Highlight New Research from its Diverse Pipeline of Targeted Cancer Therapy Candidates at the Society for Immunotherapy of Cancer’s (SITC) Annual Meeting	Businesswire
10-Nov-2022	Biodesix Presents New Data from the INSIGHT Study at the 2022 Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting	Businesswire
10-Nov-2022	IgGenix Announces Presentations on Future of Food Allergy Treatment at Gordon Research Conference	Businesswire
10-Nov-2022	WHOOP Unite and Ashley Addiction Treatment Partner to Break New Ground in Research and Patient Care	Businesswire
10-Nov-2022	Lemonex, IVI Exchange MOU on Joint Vaccine Development	Businesswire
10-Nov-2022	Repertoire® Immune Medicines Presents New Data From Its DECODE™ Platform Identifying Highly Prevalent Immunotherapeutic Targets in HPV-Positive Cancers, Unlocking Pathways for Potential Therapeutics	Businesswire
10-Nov-2022	SQZ Biotechnologies Presents Cell Squeeze® Manufacturing Platform, Linked Antigen mRNA Preclinical Research, and COMMANDER-001 Phase 1/2 Clinical Trial in Progress Poster at Society for Immunotherapy of Cancer Annual Meeting	Businesswire
10-Nov-2022	FSD Pharma Announces Arbitrator Dismisses Claims by Former CEO, Dr. Raza Bokhari	Businesswire
10-Nov-2022	Ankyra Therapeutics Presents Positive Preclinical Data Supporting Advancement of ANK-101 into Clinical Studies for Treatment of Solid Tumors	Businesswire
10-Nov-2022	Athersys Reschedules Third Quarter Conference Call to November 15	Businesswire
10-Nov-2022	Fabrinet to Present at Needham Conference	Businesswire
10-Nov-2022	Gustavo Mendes Lima Santos Joins the Simulations Plus Regulatory Fellowship Program	Businesswire